Investigación - Nuestro equipo

Dr. Vila is Research Professor at the Barcelona Institute for Global Health (ISGlobal), Head of the Clinical Microbiology Department of the Hospital Clínic of Barcelona and Professor at the School of Medicine of the University of Barcelona (UB). In addition, he leads the Antibiotic Resistance Initiative at the Barcelona Institute for Global Health (ISGlobal). His main field of research is the development of new antibiotics against multi-resistant bacteria and molecular tools for the rapid diagnosis of infectious diseases.

Dr. Vila was the Director of the Congress of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) from 2009 to 2014 and member of the ICAAC Scientific Committee for 4 years. He is currently the President of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). He has published 450 articles in peer-reviewed journals. He has two patented molecules. 

Líneas de investigación

•  Design of new antibiotics against multidrug-resistant bacteria
•  Research on the molecular bases of antimicrobial resistance
•  Development of new rapid diagnostic tools to diagnose infectious diseases

Principales publicaciones

• Rubio-Garcia E, Ferrando N, Martin N, Balleste-Delpierre C, Miro JM, Paredes R, Casals-Pascual C and Vila J. In vitro antibacterial activity of antiretroviral drugs on key commensal bacteria from the human microbiota. Frontiers in Cellular and Infection Microbiology (2024) 13:1306430. Doi: 10.3389/ fcimb. 2023.1306430.
• Fernandez-Pittol M, Bosch J, Ballesté-Delpierre C, Gonzalez C, Vasilakopoulou A, Berbel D, Riccobono E, Gatermann S, Kamotsay K, Reissier S, Szabo D, Aszalos AZ, Francius L, Volland H, Stankov-Pugès M, Rosenmöller M, Naas T, Vila J. Multicenter study to assess the use of BL-DetecTool for the detection of CTX-M-type ESBLs and carbapenemases directly from clinical specimens. Journal of Clinical Microbiology (2024) Feb 6:e0113623. Doi: 10.1128/jcm.01136-23. Epub ahead of print. PMID: 38319119.
• Cuesta, G.; Puerta-Alcalde, P.; Vergara, A.; Roses, E.; Bosch, J.; Casals-Pascual, C.; Soriano, A.; Marcos, M.Á.; Sanz, S.; Vila, J. An Assessment of a New Rapid Multiplex PCR Assay for the Diagnosis of Meningoencephalitis. Diagnostics (2024) 14, 802. Doi: 10.3390/diagnostics14080802.
• Roson-Calero N, Gomis Font MA, Ruiz-Soriano A, Just-Baringo X, Pachón-Ibáñez ME, Salvador JP, Marco MP, Giralt E, Oliver A, Ballesté-Delpierre C, Vila J. In vitro potentiation of tetracyclines in Pseudomonas aeruginosa by RW01, a new cyclic peptide. Antimicrobial Agents and Chemotherapy (2024) Dec 23: e0145924. Doi: 10.1128/aac.01459-24. Epub ahead of print. PMID: 39714156.
• Roson-Calero, N.; Lucas, J.; Gomis-Font, M.A.; de Pedro-Jové, R.; Oliver, A.; Ballesté-Delpierre, C.; Vila, J. Cyclic Peptide MV6, an Aminoglycoside Efficacy Enhancer Against Acinetobacter baumannii. Antibiotics (2024) 13, 1147. Doi: 10.3390/antibiotics13121147